Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

This study has been completed.
Sponsor:
Collaborators:
Integrated Therapeutics Group
Subsidiary of Schering-Plough
Information provided by:
Hepatitis Resource Network
ClinicalTrials.gov Identifier:
NCT00215891
First received: September 20, 2005
Last updated: October 24, 2005
Last verified: September 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given